Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib

This case report describes alopecia universalis and chronic graft-vs-host disease occurring after allogenic hematopoietic stem-cell transplantation and treated with ruxolitinib.

https://ift.tt/2NZNpyK